BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17982854)

  • 1. [Description of a peculiar form of Hodgkin's disease associated with Epstein-Barr virus infection].
    Elira Dokekias A; Koko I; Atipo Galiba FO; Martin A
    Bull Soc Pathol Exot; 2007 Oct; 100(4):261-3. PubMed ID: 17982854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-related Hodgkin's disease with central nervous system involvement and association with Epstein-Barr virus.
    Massarweh S; Udden MM; Shahab I; Kroll M; Sears DA; Lynch GR; Teh BS; Lu HH
    Am J Hematol; 2003 Mar; 72(3):216-9. PubMed ID: 12605396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-positive Hodgkin lymphoma-like earlobe lymphoid infiltrate: case report.
    Tanese K; Haratoh R; Yamamoto K; Wakabayashi A; Irie R; Miyakawa S
    Am J Dermatopathol; 2009 Dec; 31(8):838-45. PubMed ID: 19770629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sequential monitoring of plasma EBV-DNA level in a patient with EBV-positive Hodgkin lymphoma].
    Uchida E; Honma R; Igarashi A; Kurata M; Imadome K; Omoto E; Miura O; Arai A
    Rinsho Ketsueki; 2012 Jan; 53(1):87-91. PubMed ID: 22374530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
    Adiga GU; Abebe L; Wiernik PH
    Am J Hematol; 2003 Apr; 72(4):267-73. PubMed ID: 12666139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease.
    Flavell KJ; Biddulph JP; Powell JE; Parkes SE; Redfern D; Weinreb M; Nelson P; Mann JR; Young LS; Murray PG
    Br J Cancer; 2001 Aug; 85(3):350-6. PubMed ID: 11487264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
    Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated proliferative disorder presenting as Hodgkin's lymphoma and developing as aggressive natural killer-cell leukemia 19 years later: a case report of composite lymphoma.
    Oka K; Nagayama R; Mori N
    Pathol Res Pract; 2009; 205(10):730-4. PubMed ID: 19269751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes in studies of advanced Hodgkin's lymphoma.
    Johnson PW; Radford JA; Cullen MH; Sydes MR; Stenning SP; Hancock BW
    J Clin Oncol; 2006 Jul; 24(20):3309; author reply 3309-10. PubMed ID: 16829655
    [No Abstract]   [Full Text] [Related]  

  • 11. ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
    Federico M; Luminari S; Iannitto E; Polimeno G; Marcheselli L; Montanini A; La Sala A; Merli F; Stelitano C; Pozzi S; Scalone R; Di Renzo N; Musto P; Baldini L; Cervetti G; Angrilli F; Mazza P; Brugiatelli M; Gobbi PG;
    J Clin Oncol; 2009 Feb; 27(5):805-11. PubMed ID: 19124807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.
    Canellos GP
    J Clin Oncol; 2005 Jul; 23(21):4574-6. PubMed ID: 15837972
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
    Feng Q; Zak D; Daya R
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):270-6. PubMed ID: 22706493
    [No Abstract]   [Full Text] [Related]  

  • 14. FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity.
    Buchler T; Bomanji J; Lee SM
    Haematologica; 2007 Nov; 92(11):e120-1. PubMed ID: 18024389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Epstein-Barr virus in Hodgkin's lymphoma.
    Khan G
    Methods Mol Biol; 2009; 511():311-22. PubMed ID: 19347303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's disease presenting with osseous involvement.
    Chandra D; Ewton A; Baker K
    Am J Hematol; 2006 Jul; 81(7):550-1. PubMed ID: 16755566
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Subbiah V
    N Engl J Med; 2008 Feb; 358(7):743; author reply 743. PubMed ID: 18283721
    [No Abstract]   [Full Text] [Related]  

  • 18. Frosted branch angiitis associated with Epstein-Barr virus systemic infection.
    Farrando J; Fonollosa A; Segura A; Garcia-Arumi J
    Ocul Immunol Inflamm; 2008; 16(1):41-3. PubMed ID: 18379942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy and Hodgkin's lymphoma.
    Das P; Ha CS; Cox JD
    J Clin Oncol; 2005 Dec; 23(34):8914; author reply 8914-6. PubMed ID: 16314655
    [No Abstract]   [Full Text] [Related]  

  • 20. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease.
    Williamson PJ; de Berker D
    Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.